158 related articles for article (PubMed ID: 36406309)
1. MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement.
Krishnan A; Woreta TA; Vaidya D; Liu Y; Hamilton JP; Hong K; Dadabhai A; Ma M
J Clin Transl Hepatol; 2023 Feb; 11(1):38-44. PubMed ID: 36406309
[TBL] [Abstract][Full Text] [Related]
2. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
Young S; Rostambeigi N; Golzarian J; Lim N
AJR Am J Roentgenol; 2020 Jul; 215(1):215-222. PubMed ID: 32432911
[No Abstract] [Full Text] [Related]
3. Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.
Hu XG; Yang XX; Lu J; Li G; Dai JJ; Wang JM; Deng Y; Feng R
World J Gastrointest Surg; 2024 Feb; 16(2):481-490. PubMed ID: 38463353
[TBL] [Abstract][Full Text] [Related]
4. MELD-Na as a prognostic indicator of 30- and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt.
Ahmed R; Santhanam P; Rayyan Y
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1226-7. PubMed ID: 26111072
[TBL] [Abstract][Full Text] [Related]
5. Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt.
Song J; Wang X; Yan Y; Xiang T; Luo X
Eur J Gastroenterol Hepatol; 2022 Oct; 34(10):1074-1080. PubMed ID: 36062497
[TBL] [Abstract][Full Text] [Related]
6. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
[TBL] [Abstract][Full Text] [Related]
7. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.
Zhang B; Cai W; Gao F; Lin X; Qian T; Gu K; Song B; Chen T
Med Sci Monit; 2022 Jan; 28():e934057. PubMed ID: 35031594
[TBL] [Abstract][Full Text] [Related]
9. MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
Song J; Wang X; Yan Y; Xiang T; Luo X
Dig Dis Sci; 2023 Jul; 68(7):3185-3192. PubMed ID: 36715817
[TBL] [Abstract][Full Text] [Related]
10. Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS).
Delgado MG; Mertineit N; Bosch J; Baumgartner I; Berzigotti A
Dig Liver Dis; 2024 Mar; ():. PubMed ID: 38555198
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement.
Allegretti AS; Frenk NE; Li DK; Seethapathy H; Vela Parada XF; Long J; Endres P; Pratt DS; Chung RT; Ganguli S; Irani Z; Yamada K
PLoS One; 2019; 14(5):e0217442. PubMed ID: 31120995
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt.
Zhang W; Aryan M; Chen Z; Khan W; Thompson B; Kwenda E; Geller B; Morelli G
Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):435-442. PubMed ID: 34750323
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
[TBL] [Abstract][Full Text] [Related]
14. Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt.
Bai YW; Liu JC; Yang CT; Wang YL; Wang CY; Ju SG; Zhou C; Huang SJ; Li TQ; Chen Y; Yao W; Xiong B
Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):948-955. PubMed ID: 35594511
[TBL] [Abstract][Full Text] [Related]
15. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
[TBL] [Abstract][Full Text] [Related]
16. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage.
Tzeng WS; Wu RH; Lin CY; Chen JJ; Sheu MJ; Koay LB; Lee C
Korean J Radiol; 2009; 10(5):481-9. PubMed ID: 19721833
[TBL] [Abstract][Full Text] [Related]
17. [Comparison study of five scoring systems for evaluating prognosis of patients undergoing transjugular intrahepatic portosystemic shunt procedures].
Wen L; He S; Zhang H; Luo X
Zhonghua Gan Zang Bing Za Zhi; 2014 Jul; 22(7):514-8. PubMed ID: 25203803
[TBL] [Abstract][Full Text] [Related]
18. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
[TBL] [Abstract][Full Text] [Related]
19. Predictive Accuracy Comparison of Prognostic Scoring Systems for Survival in Patients Undergoing TIPS Placement: A Systematic Review and Meta-analysis.
Zhao Y; Wang Y; Xu J
Acad Radiol; 2023 Nov; ():. PubMed ID: 38000922
[TBL] [Abstract][Full Text] [Related]
20. Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt.
Ballester MP; Lluch P; Tosca J; Capilla M; Gómez C; Moreno O; Jordán-Iborra C; Sunsundegui P; Argemi J; Guijarro J; Mínguez M
Dig Liver Dis; 2021 Dec; 53(12):1596-1602. PubMed ID: 34052179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]